SCHEDULE 13G FOR MARCH 30, 2007.

Company

Altimmune, Inc.

Filed

August 20, 2007

Accession Number

0001095449-07-000036

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →